PT Indofarma Persero Tbk announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was IDR 1,359,175.249 million compared to IDR 1,592,979.941 million a year ago. Operating income was IDR 50,055.221 million compared to IDR 25,910.150 million a year ago. Net income was IDR 7,960.962 million compared to net loss of IDR 32,735.901 million a year ago. Basic earnings per share was IDR 2.57 compared to basic loss per share of IDR 10.56 a year ago.